BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11281215)

  • 21. Founder effect in a Belgian-Dutch fragile X population.
    Buyle S; Reyniers E; Vits L; De Boulle K; Handig I; Wuyts FL; Deelen W; Halley DJ; Oostra BA; Willems PJ
    Hum Genet; 1993 Oct; 92(3):269-72. PubMed ID: 8406435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fragile X syndrome in Finland: demonstration of a founder effect by analysis of microsatellite haplotypes.
    Haataja R; Väisänen ML; Li M; Ryynänen M; Leisti J
    Hum Genet; 1994 Nov; 94(5):479-83. PubMed ID: 7959680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation.
    Snow K; Tester DJ; Kruckeberg KE; Schaid DJ; Thibodeau SN
    Hum Mol Genet; 1994 Sep; 3(9):1543-51. PubMed ID: 7833909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible founder effects for FRAXE alleles.
    Limprasert P; Zhong N; Currie JR; Brown WT
    Am J Med Genet; 1999 May; 84(3):286-90. PubMed ID: 10331609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct linkage disequilibrium (LD) runs of single nucleotide polymorphisms and microsatellite markers; implications for use of mixed marker haplotypes in LD-based mapping.
    Lee KA; Sohn KM; Cho SH; Hwang H; Kim SW; Won HH; Kim HJ; Kim MJ; Cho SS; Park JH; Kim JW
    J Korean Med Sci; 2007 Jun; 22(3):425-30. PubMed ID: 17596648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragile X syndrome: genetic localisation by linkage mapping of two microsatellite repeats FRAXAC1 and FRAXAC2 which immediately flank the fragile site.
    Richards RI; Holman K; Kozman H; Kremer E; Lynch M; Pritchard M; Yu S; Mulley J; Sutherland GR
    J Med Genet; 1991 Dec; 28(12):818-23. PubMed ID: 1757956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles.
    Kunst CB; Warren ST
    Cell; 1994 Jun; 77(6):853-61. PubMed ID: 7911740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striking founder effect for the fragile X syndrome in Finland.
    Oudet C; von Koskull H; Nordström AM; Peippo M; Mandel JL
    Eur J Hum Genet; 1993; 1(3):181-9. PubMed ID: 8044645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of FMR1 (CGG)(n) alleles and DXS548-FRAXAC1 haplotypes in three European circumpolar populations: traces of genetic relationship with Asia.
    Larsen LA; Vuust J; Nystad M; Evseeva I; Van Ghelue M; Tranebjaerg L
    Eur J Hum Genet; 2001 Sep; 9(9):724-7. PubMed ID: 11571563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic epidemiology of single-nucleotide polymorphisms.
    Collins A; Lonjou C; Morton NE
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15173-7. PubMed ID: 10611357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA studies of X-linked mental retardation associated with a fragile site at Xq27.3.
    Goonewardena P; Dahl N; Gustavson KH; Holmgren G; Pettersson U
    Ups J Med Sci Suppl; 1987; 44():155-64. PubMed ID: 2895524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linkage homogeneity near the fragile X locus in normal and fragile X families.
    Suthers GK; Mulley JC; Voelckel MA; Dahl N; Väisänen ML; Steinbach P; Glass IA; Schwartz CE; van Oost BA; Thibodeau SN
    Genomics; 1991 Jul; 10(3):576-82. PubMed ID: 1889808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strong founder effect for the fragile X syndrome in Sweden.
    Malmgren H; Gustavson KH; Oudet C; Holmgren G; Pettersson U; Dahl N
    Eur J Hum Genet; 1994; 2(2):103-9. PubMed ID: 8044655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of the allelic polymorphism of the five X-linked (CA)n dinucleotide repeats in Russia].
    Drozd OV; Strel'nikov VV; Babenko OV; Zemliakova VV; Nemtsova MV; Zaletaev DV
    Genetika; 2003 Mar; 39(3):433-8. PubMed ID: 12722645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
    Baffoe-Bonnie AB; Smith JR; Stephan DA; Schleutker J; Carpten JD; Kainu T; Gillanders EM; Matikainen M; Teslovich TM; Tammela T; Sood R; Balshem AM; Scarborough SD; Xu J; Isaacs WB; Trent JM; Kallioniemi OP; Bailey-Wilson JE
    Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haplotype analysis at the FRAXA locus in Thai subjects.
    Limprasert P; Saechan V; Ruangdaraganon N; Sura T; Vasiknanote P; Jaruratanasirikul S; Brown WT
    Am J Med Genet; 2001 Jan; 98(3):224-9. PubMed ID: 11169559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Searching for evidence of positive selection in the human genome using patterns of microsatellite variability.
    Payseur BA; Cutter AD; Nachman MW
    Mol Biol Evol; 2002 Jul; 19(7):1143-53. PubMed ID: 12082133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insert size and flanking haplotype in fragile X and normal populations: possible multiple origins for the fragile X mutation.
    Macpherson JN; Bullman H; Youings SA; Jacobs PA
    Hum Mol Genet; 1994 Mar; 3(3):399-405. PubMed ID: 8012351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed replication of Xq27 in individuals with the fragile X syndrome.
    Webb T
    Am J Med Genet; 1992 Aug; 43(6):1057-62. PubMed ID: 1415338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of founder chromosomes in fragile X syndrome.
    Richards RI; Holman K; Friend K; Kremer E; Hillen D; Staples A; Brown WT; Goonewardena P; Tarleton J; Schwartz C
    Nat Genet; 1992 Jul; 1(4):257-60. PubMed ID: 1302021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.